
SPI 112
CAS No. 1051387-90-6
SPI 112( SPI-112 | SPI112 | SPI 112 )
Catalog No. M17127 CAS No. 1051387-90-6
SPI-112, the SPI-112 methyl ester analog, can inhibit cellular Shp2 PTP activity. SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 39 | In Stock |
![]() ![]() |
25MG | 77 | In Stock |
![]() ![]() |
50MG | 135 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSPI 112
-
NoteResearch use only, not for human use.
-
Brief DescriptionSPI-112, the SPI-112 methyl ester analog, can inhibit cellular Shp2 PTP activity. SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2.
-
DescriptionSPI-112, the SPI-112 methyl ester analog was able to inhibit cellular Shp2 PTP activity. SPI-112 bound to Shp2 by surface plasmon resonance (SPR) and displayed competitive inhibitor kinetics to Shp2.
-
In Vitro——
-
In Vivo——
-
SynonymsSPI-112 | SPI112 | SPI 112
-
PathwayOthers
-
TargetOther Targets
-
RecptorSHP-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1051387-90-6
-
Formula Weight468.45
-
Molecular FormulaC22H17FN4O5S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (106.73 mM)
-
SMILESO=C(O)c1cccc(N/N=C/2\C(=O)Nc3c2cc(S(=O)(=O)NCc2ccc(F)cc2)cc3)c1
-
Chemical Name(Z)-3-(2-(5-(N-(4-Fluorobenzyl)sulfamoyl)-2-oxoindolin-3-ylidene)hydrazinyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen L, et al. Biochem Pharmacol. Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112 . 2010 Sep 15;80(6):801-10
molnova catalog



related products
-
Sitafloxacin Hydrate
Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer.
-
Dibenzosuberone
Pharmaceutical intermediates for the synthesis of drug amitriptyline.
-
Ornipressin
Ornipressin is a vasoconstrictor, haemostatic and renal agent.